Drug
Alprostadil
Alprostadil: highest development phase Phase 3, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Alprostadil (Prostaglandin E1) NCT01263925 | Phase 3 | Stage II Peripheral Arterial Occlusive Disease |
Latest
No recent events.
Follow Alprostadil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.